Eye Device Maker Can't Sue Ex-Partner's Customers Over IP

Law360 (August 30, 2019, 6:22 PM EDT) -- A Michigan federal judge has barred eye disease treatment company BlephEx LLC from filing infringement litigation against customers of a former business partner's rival company, saying it’s clear their blepharitis treatments are meant for different parts of the eyelid.

U.S. District Judge Gershwin A. Drain issued a preliminary injunction on Aug. 27, blocking BlephEx LLC and its CEO James Rynerson from suing potential customers of Myco Industries Inc. and its chair John Choate. BlephEx’s eponymous product and its related patent are used on the inner edge of the eyelid, whereas Myco’s AB Max is applied on the front edge of the...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS